ACR Statement Regarding the Recent CMS Guidance on Indication-Based Formulary Design
American College of Rheumatology (ACR)While we appreciate the agency’s efforts to make prescription medications more affordable, we have serious concerns about a new CMS guidance to allow Medicare Part D plan sponsors to implement indication-based formulary designs that allow plans to select drugs for their formularies based only on the disease indications they want to use.